-
Product Insights
NewCystitis – Drugs In Development, 2024
Empower your strategies with our Cystitis – Drugs In Development, 2024 report and make more profitable business decisions. Cystitis is a bacterial infection of the bladder or lower urinary tract. It is caused by germs, usually bacteria that enter the urethra and then the bladder. These bacteria can lead to infection, most commonly in the bladder. Cystitis also may occur as a reaction to certain drugs or radiation therapy. Symptoms from a lower urinary tract infection include pain with urination, frequent...
-
Product Insights
NewProgressive Multifocal Leukoencephalopathy – Drugs In Development, 2024
Empower your strategies with our Progressive Multifocal Leukoencephalopathy – Drugs In Development, 2024 report and make more profitable business decisions. Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease of the brain caused by lytic infection of oligodendrocytes by polyomavirus, also known as JC (John Cunningham) virus. Symptoms include clumsiness, progressive weakness, and visual, speech, and sometimes personality changes. Risk factors include the presence of pathogenic JC virus and an altered or weakened immune system, and genetic or environmental factors. The Progressive...
-
Product Insights
NewHemorrhagic Cystitis (Haemorrhagic Cystitis) – Drugs In Development, 2024
Empower your strategies with our Hemorrhagic Cystitis (Haemorrhagic Cystitis) – Drugs In Development, 2024 report and make more profitable business decisions. Hemorrhagic cystitis is a bladder inflammation that causes the lining of the bladder to bleed. It is caused by toxins, pathogens, radiation, drugs, and certain medical conditions. It can also be a complication of cyclophosphamide, ifosfamide, and radiation therapy. Symptoms include hematuria, blood clots in urine, dysuria, fever, inability to urinate, and loss of bladder control. Diagnosis can be done...
-
Product Insights
NewPolyomavirus Infections – Drugs In Development, 2024
Empower your strategies with our Polyomavirus Infections – Drugs In Development, 2024 report and make more profitable business decisions. Polyomaviruses, a family of small DNA viruses, pose potential threats to human health. Among them, the BK virus (BKV) and JC virus (JCV) are known to infect humans, with implications for those with weakened immune systems. While these viruses can circulate without symptoms in the general population, immunocompromised individuals face complications. BKV may induce nephropathy or cystitis, particularly in organ transplant recipients....
-
Product Insights
NewPandemic Influenza – Drugs In Development, 2024
Empower your strategies with our Pandemic Influenza – Drugs In Development, 2024 report and make more profitable business decisions. A flu pandemic is characterized by the worldwide spread of a novel flu A virus, and it occurs when this emerging virus has the capability to efficiently infect and transmit among humans, affecting a large population with limited immunity. Such pandemics are marked by the ability of the new influenza A virus to spread easily from person to person. The most recent...
-
Product Insights
NewSeasonal Influenza – Drugs In Development, 2024
Empower your strategies with our Seasonal Influenza – Drugs In Development, 2024 report and make more profitable business decisions. Seasonal influenza, commonly referred to as "the flu", is a contagious respiratory illness caused by influenza viruses. It typically occurs in outbreaks during the fall and winter months, peaking between December and February in the Northern Hemisphere. The flu can cause mild to severe illness and, in some cases, can lead to hospitalization or even death, especially among vulnerable populations. Symptoms of...
-
Product Insights
NewAvian Influenza – Drugs In Development, 2024
Empower your strategies with our Avian Influenza – Drugs In Development, 2024 report and make more profitable business decisions. Avian influenza, commonly referred to as bird flu, is a viral infection that primarily affects birds, especially poultry such as chickens and turkeys. Various strains of avian influenza viruses exist, some of which can cause severe illness in birds and, in certain cases, pose a risk to human health. Avian influenza viruses belong to the influenza A virus family and are classified...
-
Product Insights
NewInfluenzavirus B Infections – Drugs In Development, 2024
Empower your strategies with our Influenzavirus B Infections – Drugs In Development, 2024 report and make more profitable business decisions. Type B influenza is a subtype of the influenza virus that tends to occur sporadically. Symptoms include runny nose, sore throat, aching muscles, malaise, watery eyes, aching body, loss of appetite, and weakness. Treatment includes antivirals, analgesics, and antipyretics medications. The Influenzavirus B Infections drugs in development market research report provide comprehensive information on the therapeutics under development for Influenzavirus B...
-
Product Insights
NewCytomegalovirus (HHV-5) Infections – Drugs In Development, 2024
Empower your strategies with our Cytomegalovirus (HHV-5) Infections – Drugs In Development, 2024 report and make more profitable business decisions. Cytomegalovirus (CMV) is virus in the herpes family, also called HHV-5. CMV is spread through saliva or urine. Symptoms include fever, pneumonia, weight loss, and hearing, neurological, and developmental problems. The predisposing factors are direct contact with an infected surface or individual, weakened immune system, and congenital factors. It may be diagnosed by blood or urine tests. The condition may be...
-
Product Insights
NewInfluenzavirus A Infections – Drugs In Development, 2024
Empower your strategies with our Influenzavirus A Infections – Drugs In Development, 2024 report and make more profitable business decisions. Influenza A virus infections are caused by a type of influenza virus with a high capacity for genetic variation. It is more serious than the common cold and can cause major outbreaks and severe disease. It spreads through droplets from the nose or throat of an infected person, usually through coughing and sneezing. The proteins on the surface of the influenza...